N Lynn Henry

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Manjunath Pai

Professor and Chair

University of Michigan

UNITED STATES

View details

Lajos Pusztai

Yale University

UNITED STATES

View details

Reena Cecchini

University of Pittsburgh

UNITED STATES

View details

Angela DeMichele

University of Pennsylvania

UNITED STATES

View details

Ciao-Sin Chen

University of Michigan

UNITED STATES

View details

Kristin Klein

Clinical Professor

University of Michigan

UNITED STATES

View details

Greg Yothers

Research Professor

University of Pittsburgh

UNITED STATES

View details

Paul Swiecicki

University of Michigan

UNITED STATES

View details

Daniel Hertz

University of Michigan

UNITED STATES

View details

Lesley Fallowfield

Director, Professor of Psycho-oncology

University of Sussex

UNITED KINGDOM

View details

Patricia Ganz

Professor

University of California, Los Angeles

UNITED STATES

View details

Andrew K. Godwin

University of Kansas Medical Center

UNITED STATES

View details

Richard Harris

Endowed Chair and Professor

University of California Irvine Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

N Lynn Henry

Research Interests

Explore related searches

Contact this professor

Articles (20)

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Self-acupressure for patients with breast cancer experiencing aromatase inhibitor-associated musculoskeletal symptoms: Protocol for the AcuAIM randomized pilot trial

Quantitation of Plasma Proteins to Predict Taxane-Induced Peripheral Neuropathy

Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability Data

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor–Positive Breast Cancer: ASCO Guideline Clinical Insights

Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer

Risk of Toxicity From Topical 5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles

Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository

Correction to: Impact of the Integrative Oncology Scholars Program on Oncology Providers’ Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care

Impact of the Integrative Oncology Scholars Program on Oncology Providers’ Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care

Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update

Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients

Unintended Negative Consequences of Managing Chemotherapy Toxicity

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update

Collaborators (13)

Manjunath Pai

Lajos Pusztai

Reena Cecchini

Angela DeMichele

Ciao-Sin Chen

Kristin Klein

Greg Yothers

Paul Swiecicki

Daniel Hertz

Lesley Fallowfield

Patricia Ganz

Andrew K. Godwin

Richard Harris

Make your next move.